Quitting Cigarette Smoking Results in a Fast Improvement of in vivo Oxidation Injury (Determined via Plasma, Serum and Urinary Isoprostane)

This publication has 19 references indexed in Scilit:

• F2-Isoprostane excretion rate and diurnal variation in human urine
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 1999
• The isoprostane, 8-epi-PGF2α, is accumulated in coronary arteries isolated from patients with coronary heart disease
  Cardiovascular Research, 1999
• 6-oxo-PGF1αand 8-epi-PGF2αin human atherosclerotic vascular tissue
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 1999
• 3.P.371 Isoprostanes in atherosclerotic lesions
  Atherosclerosis, 1997
• Increase in Circulating Products of Lipid Peroxidation (F₂-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
  New England Journal of Medicine, 1995
• Stimulatory Effect of 8-Epi-PGF2α, An F2-Isoprostane, on Endothelin-1 Release
  Journal of Cardiovascular Pharmacology, 1995
• Formation of PGF2-Isoprostanes During the Oxidative Modification of Low Density Lipoprotein
  Biochemical and Biophysical Research Communications, 1994
• Vascular Smooth Muscle Actions and Receptor Interactions of 8-Iso-prostaglandin E2, an E2-Isoprostane
  Biochemical and Biophysical Research Communications, 1993
• Premature deaths avoided by the antismoking campaign.
  American Journal of Public Health, 1983
• Cardiovascular effects of long-term cigarette smoking and nicotine administration
  The American Journal of Cardiology, 1976